165 related articles for article (PubMed ID: 90176)
21. Benign prostatic hyperplasia: morphometric studies in relation to the hormone sensitivity of stromal tissue.
Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
Prog Clin Biol Res; 1994; 386():51-65. PubMed ID: 7528421
[No Abstract] [Full Text] [Related]
22. Transrectal hyperthermia-induced histological and ultrastructural changes of human benign prostatic hyperplasia tissue.
Montorsi F; Guazzoni G; Colombo R; Bulfamante G; Galli L; Matozzo V; Consonni P; Rigatti P
Eur Urol; 1992; 22(1):74-8. PubMed ID: 1385146
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural aspects of human prostate in benign prostatic hyperplasia.
Biagini G; Preda P; Lo Cigno M; Soli M; Bercovich E
Prostate; 1982; 3(1):99-108. PubMed ID: 6176989
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue.
Kitada S; Kumazawa J
J Urol; 1987 Jul; 138(1):158-60. PubMed ID: 2439708
[TBL] [Abstract][Full Text] [Related]
25. The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected.
Schuster GA; Schuster TG
J Urol; 1999 Apr; 161(4):1168-73. PubMed ID: 10081863
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
27. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
28. Atypical stromal smooth muscle hyperplasia of prostate.
Leong SS; Vogt PJ; Yu GS
Urology; 1988 Feb; 31(2):163-7. PubMed ID: 2448943
[TBL] [Abstract][Full Text] [Related]
29. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
[No Abstract] [Full Text] [Related]
30. Age-related changes of histological composition in established benign prostatic hyperplasia.
Ishigooka M; Hayami S; Suzuki Y; Hashimoto T; Sasagawa I; Nakada T
Eur Urol; 1996; 29(1):85-9. PubMed ID: 8821697
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
[TBL] [Abstract][Full Text] [Related]
32. Remodeling of the muscle layer (detrusor muscle) of hyperactive bladder disease in patients with benign prostatic hyperplasia.
Nepomnyashchikh LM; Lushnikova EL; Neimark AI
Bull Exp Biol Med; 2012 Sep; 153(5):778-83. PubMed ID: 23113284
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative morphometry of hyperplastic hypoechoic nodules in the prostatic outer gland].
Li X; Wang N; Shi HY; Zhang Y; Fu XS; Li JL; Xu JH; Tang J
Zhonghua Nan Ke Xue; 2005 Feb; 11(2):91-3. PubMed ID: 15755023
[TBL] [Abstract][Full Text] [Related]
34. Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
Schweikert HU; Totzauer P; Rohr HP; Bartsch G
J Urol; 1985 Aug; 134(2):403-7. PubMed ID: 2410636
[TBL] [Abstract][Full Text] [Related]
35. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
36. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
37. Rho kinase activation mediates adrenergic and cholinergic smooth muscle contractile responses in the mouse prostate gland.
White CW; Short JL; Ventura S
Eur J Pharmacol; 2013 Dec; 721(1-3):313-21. PubMed ID: 24055190
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
Mori K; Wakasugi C
J Urol; 1985 May; 133(5):877-83. PubMed ID: 2580998
[TBL] [Abstract][Full Text] [Related]
39. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
[TBL] [Abstract][Full Text] [Related]
40. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
